A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Journal of Clinical Pathways Newsletter

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

Current Issue

Subscribe

Specialties

Events

Year Round Education

HMP Global Products